NCT00001475View on ClinicalTrials.gov

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

June 30, 1995

Study Completion Date

June 30, 2002

Conditions
Acquired Immunodeficiency SyndromeHIV Infection
Interventions
DRUG

IL-2 plus Anti-TNF or Thalidomide

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH